Get to Know Us 

Combining talent with decades of experience developing and launching life-changing treatments. Passionate about bringing cell therapies to patients.

Derrell D. Porter, MD

Chief Executive Officer and Founder

Tom Spencer, PhD

Chief Technical Officer

Sosena Woldegiorgis

SVP Finance

Philip Vorhies

Chief Business Officer

Sadie Whittaker, PhD

Chief External Affairs Officer

 

Clinical and Scientific Advisors

Steve Abella, MD

Hematology / Transplant

Alice Bertaina, MD, PhD

Hematology / Transplant

Samuel Goldlust, MD

Neurooncology

Rajiv Khanna, PhD

Virology

Michael Grimley, MD

Transplant

 

Board

Chris Jeffers, PhD, JD

Hibiscus BioVentures

Marcus Whitney

Jumpstart Nova

Eytan Abraham

Head of Cell Therapy Franchise at Resilience (Observer Seat)

 

Corporate Advisors

Morrie Ruffin

Adjuvant Partners, LC

Erich Greiner, MD

Cedrus Therapeutics Inc

Muzammil Mansuri, PhD

Former Sanofi

Anshul Mangal

Project Farma

Diane Parks

Former Kite Pharma, Inc.